http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 11 Mar 2026 02:33:52 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Downgrades/JPMorgan+Downgrades+Day+One+Biopharmaceuticals+%28DAWN%29+to+Neutral/26141633.html <p>JPMorgan analyst Anupam Rama downgraded Day One Biopharmaceuticals (NASDAQ: DAWN) from Overweight to Neutral with a price target of $21.50 (from $27.00).</p><p>The analyst comments: "We are moving to a Neutral rating post the announcement of Servier acquiring Day One and decreasing our December 2026 price target on DAWN shares to to $21.50 (prior $27), reflecting deal price."</p><p>For an analyst ratings summary and ratings history on Day One Biopharmaceuticals <a href="http://www.streetinsider.com/rating_history.php?q=DAWN">click here</a>. For more ratings news on Day One Biopharmaceuticals <a href="http://www.streetinsider.com/stock_lookup_news.php?q=DAWN&amp;type=analyst">click here</a>.</p><p>Shares of Day One Biopharmaceuticals closed at $21.28 yesterday.</p> http://www.streetinsider.com/Downgrades/JPMorgan+Downgrades+Day+One+Biopharmaceuticals+%28DAWN%29+to+Neutral/26141633.html Wed, 11 Mar 2026 02:33:52 -0400 DAWN http://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Day+One+Biopharmaceuticals+%28DAWN%29+to+Neutral/26141633.html <p>JPMorgan analyst Anupam Rama downgraded Day One Biopharmaceuticals (NASDAQ: DAWN) from Overweight to Neutral with a price target of $21.50 (from $27.00).</p><p>The analyst comments: "We are moving to a Neutral rating post the announcement of Servier acquiring Day One and decreasing our December 2026 price target on DAWN shares to to $21.50 (prior $27), reflecting deal price."</p><p>For an analyst ratings summary and ratings history on Day One Biopharmaceuticals <a href="http://www.streetinsider.com/rating_history.php?q=DAWN">click here</a>. For more ratings news on Day One Biopharmaceuticals <a href="http://www.streetinsider.com/stock_lookup_news.php?q=DAWN&amp;type=analyst">click here</a>.</p><p>Shares of Day One Biopharmaceuticals closed at $21.28 yesterday.</p> http://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+Day+One+Biopharmaceuticals+%28DAWN%29+to+Neutral/26141633.html Wed, 11 Mar 2026 02:33:52 -0400 DAWN http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Press+Releases/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039 http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html <p align="justify">NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- <strong><br/></strong></p> <p><strong>Class Action Attorney </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=B7IpbyPNkRopmhkNUjOq5waQzHd01VhxbcS19ApIfw0y_pdiQ9zXm3mJDTJKKIeKlgrUuz07PRY_GYUeHDKDjDRF1SDb8CdaKb9aaW87zhC9LZdsfXZ6eHZIP73VyryQRvO01YcrwQ254n2uN5A02NS6SffA2FDWywSi1bkrr2Fnqkwd_dD2-cG0pUJoD5ZEd_z6yw9j9tDsbwpOEIzlzw==" rel="nofollow" target="_blank">Juan Monteverde</a><strong> with </strong><a target="_blank" href="https://www.globenewswire.com/Tracker?data=LsMzOisYM6naUiAl_TZVvMYgOhhKwY4oBqdy_BtY9jp5QKGZqNIXQH_v5vAO4w78vmqoQH_CvgD5gwRiEwg7bdEPGNBZEuLh0wdzHQrzi_c03Oegc85snlYthpgtreGr" rel="nofollow" target="_blank">Monteverde &amp; Associates PC</a> (the “M&amp;A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a <strong>Top 50 Firm </strong>in the 2025 ISS Securities Class Action Services Report. We are headquartered at the<strong> Empire State Building</strong> in New York City and are investigating</p> <ul type="disc"><li style="text-align:justify;"><strong>Day One Biopharmaceuticals, Inc. (NASDAQ: </strong><a target="_blank" href="https://finance.yahoo.com/quote/DAWN/" rel="nofollow" target="_blank"><strong>DAWN</strong></a><strong>) </strong>related to its sale to Servier Pharmaceuticals LLC. Under the terms of the proposed transaction, Day One http://www.streetinsider.com/Globe+Newswire/%24HAREHOLDER+ALERT%3A+The+M%26amp%3BA+Class+Action+Firm+Is+Investigating+The+Merger%E2%80%94DAWN%2C+CECO%2C+EHAB%2C+and+KORE/26137609.html Tue, 10 Mar 2026 11:07:00 -0400 A.20172836 A.27425981 A.34495761 CECE CECO DAWN EHAB KORE O.01129058 O.01417113 O.20128147 O.21630262 O.31045076 O.50600732 O.54217039